News

Canadian General Investments Strategic Portfolio Overview

Canadian General Investments Strategic Portfolio Overview

Overview of Canadian General Investments

Canadian General Investments, Limited (NASDAQ: CGI) is a notable player in the Canadian investment landscape. As of a recent report, the net asset value per share (NAV) was recorded at $73.48, signaling a year-to-date NAV return of 6.9% and a 12-month return of 14.0%. These figures highlight a solid performance in comparison to the benchmark S&p;P/TSX Composite Index, which achieved returns of 12.0% and 21.4% respectively during the same evaluation periods.

Leverage Strategy for Enhanced Returns

The firm has adopted a strategic leveraging approach through bank borrowing, which is designed to boost returns for its common shareholders. Notably, as of the latest evaluation, leverage represented 13.0% of the company's net assets. This marks a slight decrease from the previous year, where it stood at 13.8%, yet it has seen an increase compared to 12.8% at the same time last year.

Current Share Price Performance

As for the common shares of CGI, the closing price noted was $40.60. The returns, with dividends reinvested, show 1.7% year-to-date and 3.0% over the last year, illustrating a steady upward trend despite market fluctuations.

Investment Portfolio Highlights

CGI's investment portfolio is carefully diversified across several sectors. As of the latest assessment, the sector weightings were as follows:

  • Information Technology: 24.7%
  • Industrials: 21.0%
  • Financials: 14.2%
  • Materials: 12.7%
  • Energy: 12.3%
  • Consumer Discretionary: 9.4%
  • Real Estate: 4.3%
  • Cash & Cash Equivalents: 0.7%
  • Communication Services: 0.7%

Top Investments Within the Portfolio

The top ten investments in CGI's portfolio account for 38.1% of its market value. The noteworthy companies included are:

  • Celestica Inc.: 5.6%
  • NVIDIA Corporation: 5.4%
  • WSP Global Inc.: 3.9%
  • Franco-Nevada Corporation: 3.7%
  • Dollarama Inc.: 3.4%
  • Canadian Pacific Kansas City Limited: 3.4%
  • The Descartes Systems Group Inc.: 3.4%
  • Mastercard Incorporated: 3.3%
  • Shopify Inc.: 3.1%
  • Apple Inc.: 2.9%

Contact Information for Inquiries

For those seeking further details or insights regarding Canadian General Investments, please reach out to:

Jonathan A. Morgan
President & CEO
Phone: (416) 366-2931
Fax: (416) 366-2729
Email: info@canadiangeneralinvestments.ca
Website: www.canadiangeneralinvestments.ca

Frequently Asked Questions

What is Canadian General Investments' recent NAV?

The recent net asset value (NAV) per share for Canadian General Investments is $73.48.

How much leverage does CGI utilize?

As of the latest report, CGI's leverage stands at 13.0% of its net assets.

What were the share price returns for CGI?

The share price returns with dividends reinvested are 1.7% year-to-date and 3.0% for the last year.

Which sectors dominate CGI's investment portfolio?

CGI's portfolio heavily emphasizes Information Technology and Industrials, comprising 24.7% and 21.0% respectively.

Who can be contacted for more information about CGI?

Inquiries can be directed to Jonathan A. Morgan, President & CEO, at (416) 366-2931 or via email.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 110

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 43

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
Dental Exams Are Routine Until They Catch Something Early

Updated Category News Views 60

A mouth can look perfectly fine right up until it does not. That is the unglamorous value in the dental exam and X-rays visit described by Dr. Eric Runyon of Smiles Unlimited in Belton, Missouri: it is a structured look for trouble before pain, swelling, or a cracked tooth forces the issue. Nobody throws a parade for preventive care, but waiting for symptoms has a habit...

Continue Reading
Institutions Spread AI Bets as 2027 Risks Mount Higher

Updated Category News Views 89

Money managers are not fleeing the party; they are checking the fire exits. Natixis Investment Managers surveyed 515 institutions overseeing $42.7 trillion, and their 2027 posture is pretty plain: keep taking risk, just stop pretending every risk is the same. Inflation, rates, government debt, geopolitical fracture and an AI spending boom are all tugging at portfolios at...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 148

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
es